Dlg2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value |
|---|---|
| Gene Symbol | DLG2 |
| Gene Name | Discs Large Homolog 2 (PSD-93) |
| Chromosomal Location | 11q14.1 |
| NCBI Gene ID | 1749 |
| Ensembl ID | ENSG00000150672 |
| UniProt ID | Q9UQB8 |
DLG2 (Discs Large Homolog 2), also known as PSD-93 (Postsynaptic Density protein 93), is a scaffold protein that plays critical roles in synaptic organization, signal transduction, and neuronal excitability. It is a member of the membrane-associated guanylate kinase (MAGUK) family and is predominantly expressed in the postsynaptic density of excitatory synapses. DLG2 is essential for maintaining synaptic structure and function, and its dysfunction has been implicated in various neuropsychiatric and neurodegenerative disorders.
DLG2 functions as a major postsynaptic scaffold that organizes the postsynaptic density architecture:
DLG2 interacts with numerous synaptic proteins through its multiple domains:
DLG2 is crucial for targeting and anchoring receptors to postsynaptic sites:
DLG2 serves as a signaling hub, bringing together kinases, phosphatases, and second messenger systems:
DLG2 is among the strongest schizophrenia risk genes[1]. Common and rare genetic variants in DLG2 contribute to disease risk. DLG2 expression is altered in postmortem brain tissue from schizophrenia patients, particularly in prefrontal cortex.
Rare deleterious mutations in DLG2 have been identified in autism patients[2]. These mutations may disrupt synaptic function and neural circuit development.
DLG2 expression is altered in Alzheimer's disease brains[3]. Changes in DLG2 may contribute to synaptic dysfunction through effects on NMDA receptor signaling and calcium homeostasis.
DLG2 genetic variants have been associated with PD risk in genome-wide studies. The protein may play roles in dopaminergic neuron function and survival.
DLG2 deletions and mutations cause intellectual disability, often with developmental delay and behavioral problems.
DLG2 shows highest expression in:
Expression is neuron-specific, primarily in excitatory glutamatergic neurons.
DLG2 represents a potential therapeutic target for schizophrenia and autism. Strategies include:
In AD and PD, enhancing DLG2 function may help preserve synaptic integrity:
The study of Dlg2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.